Clinical Trial Update: BE Study of Metformin GSK 850mg [Phase 2]

View source ↗

Summary

A Phase 2 bioequivalence study of metformin 850 mg from GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot

Drugs mentioned

• metformin GSK 850 mg (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetic Foot | Phase 2 | Status: COMPLETED